Overview
Tetanus Immune Globulin is manufactured from human plasma . It contains antibodies against tetanus toxoid and is primarily used as prophylaxis against tetanus in wounded patients.
Background
Tetanus Immune Globulin is manufactured from human plasma . It contains antibodies against tetanus toxoid and is primarily used as prophylaxis against tetanus in wounded patients.
Indication
For use as prophylaxis against tetanus in patients who are injured and have incomplete of uncertain immunization status . May also be used in the treatment of active tetanus.
Associated Conditions
- Tetanus
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2007/02/21 | Phase 4 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| HyperTET S/D Injection 250 units | SIN09656P | INJECTION | 250 units | 2/26/1998 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Human Tetanus Immunoglobulin | 国药准字S20063145 | 生物制品 | 注射剂 | 10/16/2020 | |
| Human Tetanus Immunoglobulin | 国药准字S20083045 | 生物制品 | 注射剂 | 2/6/2024 | |
| Human Tetanus Immunoglobulin | 国药准字S20063017 | 生物制品 | 注射剂 | 1/17/2020 | |
| Human Tetanus Immunoglobulin | 国药准字S20083114 | 生物制品 | 注射剂 | 7/26/2023 | |
| Human Tetanus Immunoglobulin | 国药准字S10880001 | 生物制品 | 注射剂(注射液) | 2/5/2020 | |
| Human Tetanus Immunoglobulin | 国药准字S20202000 | 生物制品 | 注射剂 | 6/24/2021 | |
| Human Tetanus Immunoglobulin | 国药准字S20053090 | 生物制品 | 注射剂 | 3/12/2020 | |
| Human Tetanus Immunoglobulin | 国药准字S20153006 | 生物制品 | 注射剂 | 4/3/2020 | |
| Human Tetanus Immunoglobulin | 国药准字S20043006 | 生物制品 | 注射剂 | 7/20/2020 | |
| Human Tetanus Immunoglobulin | 国药准字S20043094 | 生物制品 | 注射剂(注射液) | 3/2/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| CSL TETANUS IMMUNOGLOBULIN-VF (human) for intravenous use 4000IU injection vial | 31829 | Medicine | A | 11/4/1991 | |
| CSL New Zealand Tetanus Immunoglobulin-VF (Human Tetanus Immunoglobulin), 250IU, solution for injection, vial | 125817 | Medicine | A | 3/1/2006 | |
| CSL TETANUS IMMUNOGLOBULIN VF (human) 250IU injection vial | 61218 | Medicine | A | 10/21/1998 |